Partners
LumaCyte
Lead Partner
LumaCyte is an advanced bioanalytics company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required. This revolutionary technology utilizes Laser Force Cytology™ (LFC™) to measure the intrinsic biochemical and biophysical properties of each cell. Key applications of the technology include cell bank characterization and management, cell health monitoring, viral infectivity for vaccines and cell and gene therapy, in addition to multiple applications across the biomanufacturing sector for process optimization and quality control.
Securecell
Innovation Partner
Securecell AG is a leader in advanced bioprocess automation and digitalization, serving the biopharma industry for over 25 years. Its unique key technology portfolio enables seamlessly integrated, end-to-end workflows—from upstream development to downstream processing. Flagship solutions include Lucullus® for intelligent process control, Numera® for automated 24/7 online analytics, Integra 1 for fully automated high-throughput bioprocessing and advanced bioreactor sampling—empowering customers to accelerate innovation, improve efficiency, and scale with precision in demanding biotech environments.
Bruker
Event Partner
As a global leader in analytical instrumentation, Bruker provides a comprehensive portfolio of PAT solutions—including software, instruments, and robotics—for drug discovery, biopharmaceutical characterization, and pharmaceutical quality control. Leveraging its broad expertise and diverse product lines across multiple scientific disciplines, Bruker is uniquely positioned to deliver complete, integrated PAT solutions tailored to the complex needs of the pharmaceutical industry. Our high-performance PAT tools enhance productivity, ensure superior data quality, and enable efficient, automated workflows. Committed to advancing pharmaceutical innovation, Bruker helps accelerate time-to-market and supports the development of safe, effective therapies for patients worldwide.